- Home
- GTBP vs CELZ Comparison
GTBP vs CELZ Comparison
Compare GTBP & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- CELZ
- Stock Information
- Founded
- GTBP 1965
- CELZ 1998
- Country
- GTBP United States
- CELZ United States
- Employees
- GTBP N/A
- CELZ N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- GTBP Health Care
- CELZ Health Care
- Exchange
- GTBP Nasdaq
- CELZ Nasdaq
- Market Cap
- GTBP 5.5M
- CELZ 5.5M
- IPO Year
- GTBP N/A
- CELZ N/A
- Fundamental
- Price
- GTBP $2.68
- CELZ $2.39
- Analyst Decision
- GTBP Strong Buy
- CELZ
- Analyst Count
- GTBP 1
- CELZ 0
- Target Price
- GTBP $11.00
- CELZ N/A
- AVG Volume (30 Days)
- GTBP 86.7K
- CELZ 46.0K
- Earning Date
- GTBP 05-15-2025
- CELZ 05-09-2025
- Dividend Yield
- GTBP N/A
- CELZ N/A
- EPS Growth
- GTBP N/A
- CELZ N/A
- EPS
- GTBP N/A
- CELZ N/A
- Revenue
- GTBP N/A
- CELZ $14,000.00
- Revenue This Year
- GTBP N/A
- CELZ N/A
- Revenue Next Year
- GTBP N/A
- CELZ N/A
- P/E Ratio
- GTBP N/A
- CELZ N/A
- Revenue Growth
- GTBP N/A
- CELZ 55.56
- 52 Week Low
- GTBP $1.72
- CELZ $1.69
- 52 Week High
- GTBP $4.10
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- GTBP 56.17
- CELZ 64.49
- Support Level
- GTBP $2.56
- CELZ $2.22
- Resistance Level
- GTBP $2.82
- CELZ $2.44
- Average True Range (ATR)
- GTBP 0.30
- CELZ 0.12
- MACD
- GTBP 0.01
- CELZ 0.05
- Stochastic Oscillator
- GTBP 65.12
- CELZ 91.04
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.